SAM
AMED

Smartleaf Asset Management’s Amedisys AMED Stock Holding History

Smartleaf Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-58
Closed -$5.68K – 3004
2025
Q2 		$5.68K Sell
58
-66
-53% -$6.25K ﹤0.01% 2006
2025
Q1 		$11.5K Sell
124
-41
-25% -$3.78K ﹤0.01% 1877
2024
Q4 		$14.9K Buy
165
+43
+35% +$3.95K ﹤0.01% 1811
2024
Q3 		$11.8K Buy
122
+57
+88% +$5.56K ﹤0.01% 1662
2024
Q2 		$6.04K Buy
65
+35
+117% +$3.25K ﹤0.01% 1709
2024
Q1 		$2.77K Buy
+30
New +$2.81K ﹤0.01% 1396

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Smartleaf Asset Management's AMED Position: Q3 2025 in Review

Smartleaf Asset Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 58 shares — an estimated $5.68K sold.

Smartleaf Asset Management first reported a position in AMED in Q1 2024 and held it in 6 quarters. The position peaked at $14.9K in Q4 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Smartleaf Asset Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Smartleaf Asset Management sold 58 Amedisys shares in Q3 2025, an estimated $5.68K.
  • Smartleaf Asset Management first reported a position in Amedisys in Q1 2024 and held it in 6 quarters.
  • Smartleaf Asset Management's Amedisys position peaked at $14.9K in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Smartleaf Asset Management's 13F filing for Q3 2025, filed 5 Nov 2025.